Edwards Lifesciences Corporation Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Edwards Lifesciences Corporation (EW) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 700.00 thousand shares for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2020-10-26
- Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-09-30 was 100.00K shares.
- Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2011-12-31 was 0.00 shares.
- Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2011-09-30 was 0.00 shares.
- Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2013 was 300.00K shares, a 0.00% change from fiscal 2012.
- Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2012 was 300.00K shares, a 50.00% increase from fiscal 2011.
- Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2011 was 200.00K shares, a 33.33% decline from fiscal 2010.
- Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2010 was 300.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2020-09-30 | 100.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | 700.00K shares 10-Q · filed 2020-10-26 | ||
| 2020-06-30 | 600.00K shares 10-Q · filed 2020-07-27 | |||
| 2013-12-31 | 300.00K shares 10-K · filed 2014-02-28 | |||
| 2012-12-31 | 300.00K shares 10-K · filed 2013-02-28 | |||
| 2011-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2012-02-27 | 200.00K shares 10-K · filed 2012-02-27 | |
| 2011-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | 200.00K shares 10-Q · filed 2011-11-08 | ||
| 2011-06-30 | 200.00K shares 10-Q · filed 2011-08-08 | |||
| 2010-12-31 | 300.00K shares 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |